Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
Fortress Biotech Inc (NQ: FBIO)
1.850 USD  +0.080 (+4.52%)
Official Closing Price  /  Updated: 4:35 PM EDT, May 24, 2019  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 228,400
Open 1.820
Bid (Size) 1.750 (6)
Ask (Size) 1.950 (166)
Prev. Close 1.770
Today's Range 1.780 - 1.870
52wk Range 0.4900 - 3.600
Shares Outstanding 52,902,146
Dividend Yield N/A
Performance
YTD
+69.72%
+69.72%
1 Month
+1.09%
+1.09%
3 Month
-13.95%
-13.95%
6 Month
+39.10%
+39.10%
1 Year
-40.89%
-40.89%
Top News
More News
Mustang Bio and St. Jude Children’s Research Hospital to Participate in Panel Discussion at Boston CEO 2019
Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO), a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs in cell and gene therapies into potential cures for... Read More
from GlobeNewswire News Releases
Mustang Bio and Nationwide Children’s Hospital Receive Orphan Drug Designation for MB-108 (Oncolytic Virus C134) for the Treatment of Malignant Glioma
Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO), a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs in cell and gene therapies into potential cures for... Read More
from GlobeNewswire News Releases
More News
Read More
Mustang Bio to Present at the Cell & Gene Therapy USA Congress 2019
from GlobeNewswire News Releases
Avenue Therapeutics Reports First Quarter 2019 Financial Results and Recent Corporate Highlights
from GlobeNewswire News Releases
Fortress Biotech Reports First Quarter 2019 Financial Results and Recent Corporate Highlights
from GlobeNewswire News Releases
Mustang Bio Reports First Quarter 2019 Financial Results and Recent Corporate Highlights
from GlobeNewswire News Releases
Checkpoint Therapeutics Reports First Quarter 2019 Financial Results and Recent Corporate Highlights
from GlobeNewswire News Releases
Mustang Bio Announces Full Exercise of Option
from GlobeNewswire News Releases
Mustang Bio Announces City of Hope Opens First-of-Its-Kind Multiple Myeloma CAR T Cell Therapy Trial Targeting CS1 Protein
from GlobeNewswire News Releases
Checkpoint Therapeutics Announces Positive Interim Clinical Results of Anti-PD-L1 Antibody Cosibelimab
from GlobeNewswire News Releases
Mustang Bio Announces Pricing of Public Offering of Common Stock
from GlobeNewswire News Releases
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.